The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Pulmatrix Inc. - Developing Inhaled Therapies to Address Pulmonary Disease Using its iSPERSE™ Technology

In this SNNLive On-Location, our host spoke with Robert Clarke, Ph.D., CEO of Pulmatrix, Inc. (NASDAQ: PULM) in New York City, NY.

Share With

Thursday, October 08, 2015

   

© 2017 Stock News Now